Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 147

1.

A comparison of fluoxetine imipramine and placebo in patients with bipolar depressive disorder.

Cohn JB, Collins G, Ashbrook E, Wernicke JF.

Int Clin Psychopharmacol. 1989 Oct;4(4):313-22.

PMID:
2607128
2.

A comparison of fluoxetine, imipramine, and placebo in patients with major depressive disorder.

Cohn JB, Wilcox C.

J Clin Psychiatry. 1985 Mar;46(3 Pt 2):26-31.

PMID:
3882677
3.

Fluoxetine in depressed patients: a comparison with imipramine.

Bremner JD.

J Clin Psychiatry. 1984 Oct;45(10):414-9.

PMID:
6384203
4.
5.

A double-blind comparison of fluoxetine, imipramine and placebo in outpatients with major depression.

Feighner JP, Boyer WF, Merideth CH, Hendrickson GG.

Int Clin Psychopharmacol. 1989 Apr;4(2):127-34.

PMID:
2663975
6.
7.
8.

A comparison of fluoxetine and imipramine in the treatment of outpatients with major depressive disorder.

Nielsen BM, Behnke K, Arup P, Christiansen PE, Geisler A, Ipsen E, Maach-Møller B, Ohrberg SC.

Acta Psychiatr Scand. 1993 Apr;87(4):269-72.

PMID:
8488748
9.

A randomized, double-blind, placebo-controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder.

Bowden CL, Grunze H, Mullen J, Brecher M, Paulsson B, Jones M, Vågerö M, Svensson K.

J Clin Psychiatry. 2005 Jan;66(1):111-21.

PMID:
15669897
10.

A double-blind trial of fluoxetine, 20 mg, and placebo in out-patients with DSM-III-R major depression and melancholia.

Heiligenstein JH, Tollefson GD, Faries DE.

Int Clin Psychopharmacol. 1993 Winter;8(4):247-51.

PMID:
8277143
11.

Placebo response in depression: a search for predictors.

Brown WA, Dornseif BE, Wernicke JF.

Psychiatry Res. 1988 Dec;26(3):259-64.

PMID:
3065807
12.

Fluoxetine, a selective serotonin uptake inhibitor, for the treatment of outpatients with major depression.

Byerley WF, Reimherr FW, Wood DR, Grosser BI.

J Clin Psychopharmacol. 1988 Apr;8(2):112-5.

PMID:
3286684
13.

Fluoxetine compared with imipramine in the treatment of inpatient depression. A multicenter trial.

Beasley CM Jr, Holman SL, Potvin JH.

Ann Clin Psychiatry. 1993 Sep;5(3):199-207.

PMID:
8281243
14.

Lithium carbonate and imipramine in the prophylaxis of unipolar and bipolar II illness: a prospective, placebo-controlled comparison.

Kane JM, Quitkin FM, Rifkin A, Ramos-Lorenzi JR, Nayak DD, Howard A.

Arch Gen Psychiatry. 1982 Sep;39(9):1065-9.

PMID:
6810839
15.

A double-blind comparison of nefazodone, imipramine, and placebo in major depression.

Fontaine R, Ontiveros A, Elie R, Kensler TT, Roberts DL, Kaplita S, Ecker JA, Faludi G.

J Clin Psychiatry. 1994 Jun;55(6):234-41.

PMID:
8071277
16.

Efficacy and safety of fluoxetine in treating bipolar II major depressive episode.

Amsterdam JD, Garcia-España F, Fawcett J, Quitkin FM, Reimherr FW, Rosenbaum JF, Schweizer E, Beasley C.

J Clin Psychopharmacol. 1998 Dec;18(6):435-40.

PMID:
9864074
17.

A Double-blind, randomized trial of St John's wort, fluoxetine, and placebo in major depressive disorder.

Fava M, Alpert J, Nierenberg AA, Mischoulon D, Otto MW, Zajecka J, Murck H, Rosenbaum JF.

J Clin Psychopharmacol. 2005 Oct;25(5):441-7.

PMID:
16160619
18.

Changes in energy during treatment of depression: an analysis of fluoxetine in double-blind, placebo-controlled trials.

Judge R, Plewes JM, Kumar V, Koke SC, Kopp JB.

J Clin Psychopharmacol. 2000 Dec;20(6):666-72.

PMID:
11106139
19.

A double-blind study of paroxetine, fluoxetine, and placebo in outpatients with major depression.

Fava M, Amsterdam JD, Deltito JA, Salzman C, Schwaller M, Dunner DL.

Ann Clin Psychiatry. 1998 Dec;10(4):145-50.

PMID:
9988054
20.

Comparison of venlafaxine and imipramine in the acute treatment of major depression in outpatients.

Schweizer E, Feighner J, Mandos LA, Rickels K.

J Clin Psychiatry. 1994 Mar;55(3):104-8.

PMID:
8071246

Supplemental Content

Support Center